Another new drug for colon cancer

Zaltrap (ziv-aflibercept), in combination with 5-FU, leucovorin, irinotecan (FOLFIRI), has now been approved for patients with metastatic colorectal cancer that is resistant to or has progressed following an oxaliplatin-containing regimen.  It works by inhibiting the growth of blood vessels that help supply nutrients to the tumor.